News | Neuro Imaging | June 12, 2018

UCLA study uses Neuroreader software to measure brain shrinkage patterns on MRI scans

Reduced hippocampal volume on MRI

This figure shows reduced hippocampal volume over the course of 6 years as seen on progressive volumetric analysis and also coronal MRI evaluations (arrows).Progressive volume loss in the mesial temporal lobe on MRI is a characteristic imaging feature of AD. This patient was a case of Alzheimer’s Dementia.

 


June 12, 2018 — According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when memory loss is caused by treatable issues other than Alzheimer’s Disease. The study was presented at the 2018 American Academy of Neurology Conference, April 21-27 in Los Angeles.

Alzheimer’s is the most common cause of memory problems in the elderly, but there are several treatable problems with similar symptoms, including vascular diseases such as hypertension, alcohol use and psychiatric disorders.

The new technology was the U.S. Food and Drug Administration (FDA)-cleared Neuroreader volumetric software. The software was applied to traditional magnetic resonance imaging (MRI) scans to analyze 22 patients, and found that only five showed brain shrinkage patterns characteristic of Alzheimer’s. The majority of the remaining cases were a combination of other causes, such as bipolar disorder and vascular disease.

For more information: www.brainreader.net


Related Content

News | Radiology Business

May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent ...

Time May 29, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Pediatric Imaging

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
Subscribe Now